UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 09, 2024 MEI Pharma, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-41827 51-0407811 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No .) 11455 El Camino Real, Suite 250 San Diego, California 92130 (Address of P ...